MarketResearchReports.biz has announced the addition of a report, titled “Global Immunoglobulin Products Market2016-2020.” According to the report, the global immunoglobulin products market is expected to expand at a 6.84% CAGR from 2016 to 2020, reaching US$12 bn. The report covers the market’s landscape and its growth prospects over the years.
The report provides an in-depth market analysis of the immunoglobulin products market, which includes the industry policy analysis and industry news analysis of the global immunoglobulin products market. The growth prospects, key trends, drivers, and opportunities of the market are discussed in detail. A comprehensive overview of the immunoglobulin products market, including its definition, specifications, classification, application, and industry chain structure, is presented in the report.
Immunoglobulins or antibodies are proteins that help in the neutralization of unwanted foreign objects in the body, such as viruses and bacteria. Immunoglobulin products were developed to treat immune deficiency. Immunoglobulin can be administered by intravenous and subcutaneous routes. Immunoglobulin products are mostly used for the treatment of antibody deficiencies, life-threatening infections, and complex immune deficiency disorders.
Immunoglobulin products prevent infections and help improve the quality of life and life expectancy of the patient. Immunoglobulin products can be used for the treatment of rare diseases, including genetic disorders. The high demand as a result of this has led to growth of the global immunoglobulin products market.
The global immunoglobulin products market is driven by the high demand from regions such as the Americas and Europe. The U.S. and the EU collectively accounted for the maximum share in the global immunoglobulin products market in 2015. The global immunoglobulin products market in APAC is expected to reach US$1.3 bn by 2020, expanding at a 9% CAGR between 2016 and 2020. The rising geriatric population and the subsequently rising number of cases of immune deficiency disorders and autoimmune disorders are driving the market. The high demand for better health management and improvement in the economic conditions in APAC are also encouraging the market’s growth. On the other hand, the market is expected to be restricted by the high cost of immunoglobulin products and the relatively weak economic conditions in emerging markets at present.
The leading players operating in the immunoglobulin products market have been profiled for the purpose of study. A business overview, financial overview, recent developments, and contact information have been included for each of the companies. Moreover, the strategies implemented by the leading players, the obstacles that have held them back, and the driving forces that have enabled them to become successful in their venture have also been included.
The key players operating in the immunoglobulin products market include: CSL, Abeona Therapeutics, Admabiologics, Anthera, Bharat Serums and Vaccines (India), Bio Products Laboratory, Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Immunomedics, Baxalta, Grifols, Octapharma, Kedrion, and Biotest Pharmaceuticals.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com